Pretreatment with probiotic Bifico ameliorates colitis‐associated cancer in mice: Transcriptome and gut flora profiling
Open Access
- 30 December 2017
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 109 (3) , 666-677
Abstract
Individuals with inflammatory bowel disease are at high risk of developing colitis‐associated cancer (CAC). Strategies to block the process from inflammatory bowel disease to CAC should be considered. In the experiment, we aim to explore the chemopreventive efficacy of the probiotic cocktail Bifico and its potential mechanism in azoxymethane and dextran sodium sulphate‐induced CAC in mice. Oral pretreatment of Bifico was adopted to evaluate its protective effect. The colorectums of 35 C57BL/6 mice were collected and examined for the degree of inflammation and tumorigenesis. Comparative 16S rRNA sequencing was carried out to observe Bifico‐target alterations in gene expression and microbiota structure. We found that pretreatment of Bifico alleviated intestinal inflammation and reduced tumor formation. Furthermore, we identified a subset of genes as potential targets of Bifico treatment, including CXCL1, CXCL2, CXCL3, and CXCL5, which are all ligands of C‐X‐C motif receptor 2 (CXCR2). The 16S rRNA sequencing showed that Bifico decreased the abundance of genera Desulfovibrio, Mucispirillum, and Odoribacter, and a bloom of genus Lactobacillus was detected. Notably, we found that an abundance of these Bifico‐target taxa was significantly associated with the expression of CXCR2 ligand genes. Our studies indicate that Bifico, given orally, can ameliorate CAC in mice through intervening with the possible link between Desulfovibrio, Mucispirillum, Odoribacter, Lactobacillus, and CXCR2 signaling.Keywords
Funding Information
- Shanghai Municipal Population and Family Planning Commission (XBR2013125)
- National Natural Science Foundation of China (31601114, 31671415, 81072010, 81372309, 81402376)
This publication has 57 references indexed in Scilit:
- VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancerScientific Reports, 2013
- The SILVA ribosomal RNA gene database project: improved data processing and web-based toolsNucleic Acids Research, 2012
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- UCHIME improves sensitivity and speed of chimera detectionBioinformatics, 2011
- Search and clustering orders of magnitude faster than BLASTBioinformatics, 2010
- Immunity, Inflammation, and CancerCell, 2010
- The role of chemokines in intestinal inflammation and cancerCurrent Opinion in Pharmacology, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Inflammation and cancerNature, 2002